Index by author

November 01 2000; volume 23 issue 11

A

  1. Abe, T

    1. Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?
      Y Nagai, T Hayakawa, T Abe and G Nomura
      Diabetes Care 2000 Nov; 23 (11): 1703. https://doi.org/10.2337/diacare.23.11.1703b

  2. Aiello, L P

    1. von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes.
      D Feng, S E Bursell, A C Clermont, I Lipinska, L P Aiello, L Laffel, G L King and G H Tofler
      Diabetes Care 2000 Nov; 23 (11): 1694-1698. https://doi.org/10.2337/diacare.23.11.1694

  3. Anhalt, H

    1. Are tumor necrosis factor-alpha receptor 2 levels associated with age?
      W Taha, I Paz-Priel and H Anhalt
      Diabetes Care 2000 Nov; 23 (11): 1713-1715. https://doi.org/10.2337/diacare.23.11.1713

  4. Aronoff, S

    1. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
      S Aronoff, S Rosenblatt, S Braithwaite, J W Egan, A L Mathisen and R L Schneider
      Diabetes Care 2000 Nov; 23 (11): 1605-1611. https://doi.org/10.2337/diacare.23.11.1605

B

  1. Balfour, J

    1. Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study.
      H E Resnick, A I Vinik, A V Schwartz, S G Leveille, F L Brancati, J Balfour and J M Guralnik
      Diabetes Care 2000 Nov; 23 (11): 1642-1647. https://doi.org/10.2337/diacare.23.11.1642

  2. Bell, R A

    1. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study.
      R A Bell, E J Mayer-Davis, M A Martin, R B D'Agostino and S M Haffner
      Diabetes Care 2000 Nov; 23 (11): 1630-1636. https://doi.org/10.2337/diacare.23.11.1630

  3. Benhamou, P Y

    1. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.
      R Boizel, P Y Benhamou, B Lardy, F Laporte, T Foulon and S Halimi
      Diabetes Care 2000 Nov; 23 (11): 1679-1685. https://doi.org/10.2337/diacare.23.11.1679

  4. Bergenstal, R

    1. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
      P Raskin, L Klaff, R Bergenstal, J P Hallé, D Donley and T Mecca
      Diabetes Care 2000 Nov; 23 (11): 1666-1671. https://doi.org/10.2337/diacare.23.11.1666

  5. Bergholm, R

    1. Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.
      S Mäkimattila, A Schlenzka, M Mäntysaari, R Bergholm, P Summanen, P Saar, H Erkkilä and H Yki-Järvinen
      Diabetes Care 2000 Nov; 23 (11): 1686-1693. https://doi.org/10.2337/diacare.23.11.1686

  6. Bloomgarden, Z T

    1. American Diabetes Association 60th Scientific Sessions, 2000: diabetes and pregnancy.
      Z T Bloomgarden
      Diabetes Care 2000 Nov; 23 (11): 1699-1702. https://doi.org/10.2337/diacare.23.11.1699

  7. Boizel, R

    1. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.
      R Boizel, P Y Benhamou, B Lardy, F Laporte, T Foulon and S Halimi
      Diabetes Care 2000 Nov; 23 (11): 1679-1685. https://doi.org/10.2337/diacare.23.11.1679

  8. Braithwaite, S

    1. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
      S Aronoff, S Rosenblatt, S Braithwaite, J W Egan, A L Mathisen and R L Schneider
      Diabetes Care 2000 Nov; 23 (11): 1605-1611. https://doi.org/10.2337/diacare.23.11.1605

  9. Brancati, F L

    1. Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study.
      H E Resnick, A I Vinik, A V Schwartz, S G Leveille, F L Brancati, J Balfour and J M Guralnik
      Diabetes Care 2000 Nov; 23 (11): 1642-1647. https://doi.org/10.2337/diacare.23.11.1642

  10. Brown, J B

    1. Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis.
      G A Nichols, H S Glauber and J B Brown
      Diabetes Care 2000 Nov; 23 (11): 1654-1659. https://doi.org/10.2337/diacare.23.11.1654

  11. Bursell, S E

    1. von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes.
      D Feng, S E Bursell, A C Clermont, I Lipinska, L P Aiello, L Laffel, G L King and G H Tofler
      Diabetes Care 2000 Nov; 23 (11): 1694-1698. https://doi.org/10.2337/diacare.23.11.1694

C

  1. Carreras, G

    1. Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients?
      G Carreras, D Mauricio, A Pérez and A de Leiva
      Diabetes Care 2000 Nov; 23 (11): 1715-1716. https://doi.org/10.2337/diacare.23.11.1715a

  2. Caspersen, C J

    1. Moderate-intensity physical activity and fasting insulin levels in women.
      C J Caspersen, M M Zack and J E Fulton
      Diabetes Care 2000 Nov; 23 (11): 1712-1713. https://doi.org/10.2337/diacare.23.11.1712

  3. Chen, Y

    1. Prevalence of diabetes in Canadian adults aged 40 years or older.
      M Tang and Y Chen
      Diabetes Care 2000 Nov; 23 (11): 1704-1705. https://doi.org/10.2337/diacare.23.11.1704

  4. Chiang, M T

    1. Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia.
      T S Tai, W H Sheu, W J Lee, H T Yao and M T Chiang
      Diabetes Care 2000 Nov; 23 (11): 1703-1704. https://doi.org/10.2337/diacare.23.11.1703a

  5. Clermont, A C

    1. von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes.
      D Feng, S E Bursell, A C Clermont, I Lipinska, L P Aiello, L Laffel, G L King and G H Tofler
      Diabetes Care 2000 Nov; 23 (11): 1694-1698. https://doi.org/10.2337/diacare.23.11.1694

  6. Clinkingbeard, C

    1. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.
      E S Horton, C Clinkingbeard, M Gatlin, J Foley, S Mallows and S Shen
      Diabetes Care 2000 Nov; 23 (11): 1660-1665. https://doi.org/10.2337/diacare.23.11.1660

  7. Cohen, R M

    1. Implications of linking pharmacy and laboratory data to assess diabetes care.
      R M Cohen
      Diabetes Care 2000 Nov; 23 (11): 1603-1604. https://doi.org/10.2337/diacare.23.11.1603

  8. Cotta, L

    1. Relevance of the treatment facility for disease-related knowledge of diabetic patients.
      M Rose, M Hildebrandt, H Fliege, B Seidlitz, L Cotta, T Schirop and B F Klapp
      Diabetes Care 2000 Nov; 23 (11): 1708-1709. https://doi.org/10.2337/diacare.23.11.1708

D

  1. D'Agostino, R B

    1. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study.
      R A Bell, E J Mayer-Davis, M A Martin, R B D'Agostino and S M Haffner
      Diabetes Care 2000 Nov; 23 (11): 1630-1636. https://doi.org/10.2337/diacare.23.11.1630

  2. Daneman, D

    1. School attendance of children with type 1 diabetes.
      J Vetiska, L Glaab, K Perlman and D Daneman
      Diabetes Care 2000 Nov; 23 (11): 1706-1707. https://doi.org/10.2337/diacare.23.11.1706

  3. Davies, R

    1. Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study.
      R Taylor, R Davies, C Fox, M Sampson, J U Weaver and L Wood
      Diabetes Care 2000 Nov; 23 (11): 1612-1618. https://doi.org/10.2337/diacare.23.11.1612

  4. de Leiva, A

    1. Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients?
      G Carreras, D Mauricio, A Pérez and A de Leiva
      Diabetes Care 2000 Nov; 23 (11): 1715-1716. https://doi.org/10.2337/diacare.23.11.1715a

  5. Dewitte, K

    1. Evaluating clinical accuracy of systems for self-monitoring of blood glucose by error grid analysis: comment on constructing the "upper A-line".
      D Stöckl, K Dewitte, C Fierens and L M Thienpont
      Diabetes Care 2000 Nov; 23 (11): 1711-1712. https://doi.org/10.2337/diacare.23.11.1711

  6. Donley, D

    1. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
      P Raskin, L Klaff, R Bergenstal, J P Hallé, D Donley and T Mecca
      Diabetes Care 2000 Nov; 23 (11): 1666-1671. https://doi.org/10.2337/diacare.23.11.1666

E

  1. Egan, J W

    1. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
      S Aronoff, S Rosenblatt, S Braithwaite, J W Egan, A L Mathisen and R L Schneider
      Diabetes Care 2000 Nov; 23 (11): 1605-1611. https://doi.org/10.2337/diacare.23.11.1605

  2. Erkkilä, H

    1. Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.
      S Mäkimattila, A Schlenzka, M Mäntysaari, R Bergholm, P Summanen, P Saar, H Erkkilä and H Yki-Järvinen
      Diabetes Care 2000 Nov; 23 (11): 1686-1693. https://doi.org/10.2337/diacare.23.11.1686

F

  1. Feng, D

    1. von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes.
      D Feng, S E Bursell, A C Clermont, I Lipinska, L P Aiello, L Laffel, G L King and G H Tofler
      Diabetes Care 2000 Nov; 23 (11): 1694-1698. https://doi.org/10.2337/diacare.23.11.1694

  2. Fierens, C

    1. Evaluating clinical accuracy of systems for self-monitoring of blood glucose by error grid analysis: comment on constructing the "upper A-line".
      D Stöckl, K Dewitte, C Fierens and L M Thienpont
      Diabetes Care 2000 Nov; 23 (11): 1711-1712. https://doi.org/10.2337/diacare.23.11.1711

  3. Fliege, H

    1. Relevance of the treatment facility for disease-related knowledge of diabetic patients.
      M Rose, M Hildebrandt, H Fliege, B Seidlitz, L Cotta, T Schirop and B F Klapp
      Diabetes Care 2000 Nov; 23 (11): 1708-1709. https://doi.org/10.2337/diacare.23.11.1708

  4. Foley, J

    1. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.
      E S Horton, C Clinkingbeard, M Gatlin, J Foley, S Mallows and S Shen
      Diabetes Care 2000 Nov; 23 (11): 1660-1665. https://doi.org/10.2337/diacare.23.11.1660

  5. Foulon, T

    1. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.
      R Boizel, P Y Benhamou, B Lardy, F Laporte, T Foulon and S Halimi
      Diabetes Care 2000 Nov; 23 (11): 1679-1685. https://doi.org/10.2337/diacare.23.11.1679

  6. Fox, C

    1. Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study.
      R Taylor, R Davies, C Fox, M Sampson, J U Weaver and L Wood
      Diabetes Care 2000 Nov; 23 (11): 1612-1618. https://doi.org/10.2337/diacare.23.11.1612

  7. Fulton, J E

    1. Moderate-intensity physical activity and fasting insulin levels in women.
      C J Caspersen, M M Zack and J E Fulton
      Diabetes Care 2000 Nov; 23 (11): 1712-1713. https://doi.org/10.2337/diacare.23.11.1712

G

  1. Gatlin, M

    1. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.
      E S Horton, C Clinkingbeard, M Gatlin, J Foley, S Mallows and S Shen
      Diabetes Care 2000 Nov; 23 (11): 1660-1665. https://doi.org/10.2337/diacare.23.11.1660

  2. Glaab, L

    1. School attendance of children with type 1 diabetes.
      J Vetiska, L Glaab, K Perlman and D Daneman
      Diabetes Care 2000 Nov; 23 (11): 1706-1707. https://doi.org/10.2337/diacare.23.11.1706

  3. Glauber, H S

    1. Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis.
      G A Nichols, H S Glauber and J B Brown
      Diabetes Care 2000 Nov; 23 (11): 1654-1659. https://doi.org/10.2337/diacare.23.11.1654

  4. Guralnik, J M

    1. Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study.
      H E Resnick, A I Vinik, A V Schwartz, S G Leveille, F L Brancati, J Balfour and J M Guralnik
      Diabetes Care 2000 Nov; 23 (11): 1642-1647. https://doi.org/10.2337/diacare.23.11.1642

H

  1. Haddow, J E

    1. Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis.
      M L Mitchell, R J Hermos, C A Larson, G E Palomaki and J E Haddow
      Diabetes Care 2000 Nov; 23 (11): 1705-1706. https://doi.org/10.2337/diacare.23.11.1705

  2. Haffner, S M

    1. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study.
      R A Bell, E J Mayer-Davis, M A Martin, R B D'Agostino and S M Haffner
      Diabetes Care 2000 Nov; 23 (11): 1630-1636. https://doi.org/10.2337/diacare.23.11.1630

  3. Halimi, S

    1. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.
      R Boizel, P Y Benhamou, B Lardy, F Laporte, T Foulon and S Halimi
      Diabetes Care 2000 Nov; 23 (11): 1679-1685. https://doi.org/10.2337/diacare.23.11.1679

  4. Hallé, J P

    1. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
      P Raskin, L Klaff, R Bergenstal, J P Hallé, D Donley and T Mecca
      Diabetes Care 2000 Nov; 23 (11): 1666-1671. https://doi.org/10.2337/diacare.23.11.1666

  5. Hayakawa, T

    1. Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?
      Y Nagai, T Hayakawa, T Abe and G Nomura
      Diabetes Care 2000 Nov; 23 (11): 1703. https://doi.org/10.2337/diacare.23.11.1703b

  6. Hermos, R J

    1. Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis.
      M L Mitchell, R J Hermos, C A Larson, G E Palomaki and J E Haddow
      Diabetes Care 2000 Nov; 23 (11): 1705-1706. https://doi.org/10.2337/diacare.23.11.1705

  7. Hildebrandt, M

    1. Relevance of the treatment facility for disease-related knowledge of diabetic patients.
      M Rose, M Hildebrandt, H Fliege, B Seidlitz, L Cotta, T Schirop and B F Klapp
      Diabetes Care 2000 Nov; 23 (11): 1708-1709. https://doi.org/10.2337/diacare.23.11.1708

  8. Hoogwerf, B J

    1. Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis.
      D L Sprecher, G L Pearce, E M Park, F J Pashkow and B J Hoogwerf
      Diabetes Care 2000 Nov; 23 (11): 1648-1653. https://doi.org/10.2337/diacare.23.11.1648

  9. Horton, E S

    1. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.
      E S Horton, C Clinkingbeard, M Gatlin, J Foley, S Mallows and S Shen
      Diabetes Care 2000 Nov; 23 (11): 1660-1665. https://doi.org/10.2337/diacare.23.11.1660

K

  1. Kiess, W

    1. "Lady-like": is there a latent autoimmune diabetes in the young?
      T Lohmann, U Nietzschmann and W Kiess
      Diabetes Care 2000 Nov; 23 (11): 1707-1708. https://doi.org/10.2337/diacare.23.11.1707

  2. King, G L

    1. von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes.
      D Feng, S E Bursell, A C Clermont, I Lipinska, L P Aiello, L Laffel, G L King and G H Tofler
      Diabetes Care 2000 Nov; 23 (11): 1694-1698. https://doi.org/10.2337/diacare.23.11.1694

  3. Klaff, L

    1. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
      P Raskin, L Klaff, R Bergenstal, J P Hallé, D Donley and T Mecca
      Diabetes Care 2000 Nov; 23 (11): 1666-1671. https://doi.org/10.2337/diacare.23.11.1666

  4. Klapp, B F

    1. Relevance of the treatment facility for disease-related knowledge of diabetic patients.
      M Rose, M Hildebrandt, H Fliege, B Seidlitz, L Cotta, T Schirop and B F Klapp
      Diabetes Care 2000 Nov; 23 (11): 1708-1709. https://doi.org/10.2337/diacare.23.11.1708

L

  1. Laffel, L

    1. von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes.
      D Feng, S E Bursell, A C Clermont, I Lipinska, L P Aiello, L Laffel, G L King and G H Tofler
      Diabetes Care 2000 Nov; 23 (11): 1694-1698. https://doi.org/10.2337/diacare.23.11.1694

  2. Laporte, F

    1. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.
      R Boizel, P Y Benhamou, B Lardy, F Laporte, T Foulon and S Halimi
      Diabetes Care 2000 Nov; 23 (11): 1679-1685. https://doi.org/10.2337/diacare.23.11.1679

  3. Lardy, B

    1. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.
      R Boizel, P Y Benhamou, B Lardy, F Laporte, T Foulon and S Halimi
      Diabetes Care 2000 Nov; 23 (11): 1679-1685. https://doi.org/10.2337/diacare.23.11.1679

  4. Larson, C A

    1. Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis.
      M L Mitchell, R J Hermos, C A Larson, G E Palomaki and J E Haddow
      Diabetes Care 2000 Nov; 23 (11): 1705-1706. https://doi.org/10.2337/diacare.23.11.1705

  5. Lee, W J

    1. Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia.
      T S Tai, W H Sheu, W J Lee, H T Yao and M T Chiang
      Diabetes Care 2000 Nov; 23 (11): 1703-1704. https://doi.org/10.2337/diacare.23.11.1703a

  6. Leveille, S G

    1. Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study.
      H E Resnick, A I Vinik, A V Schwartz, S G Leveille, F L Brancati, J Balfour and J M Guralnik
      Diabetes Care 2000 Nov; 23 (11): 1642-1647. https://doi.org/10.2337/diacare.23.11.1642

  7. Lipinska, I

    1. von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes.
      D Feng, S E Bursell, A C Clermont, I Lipinska, L P Aiello, L Laffel, G L King and G H Tofler
      Diabetes Care 2000 Nov; 23 (11): 1694-1698. https://doi.org/10.2337/diacare.23.11.1694

  8. Lithner, F

    1. Venlafaxine in treatment of severe painful peripheral diabetic neuropathy.
      F Lithner
      Diabetes Care 2000 Nov; 23 (11): 1710-1711. https://doi.org/10.2337/diacare.23.11.1710

  9. Lohmann, T

    1. "Lady-like": is there a latent autoimmune diabetes in the young?
      T Lohmann, U Nietzschmann and W Kiess
      Diabetes Care 2000 Nov; 23 (11): 1707-1708. https://doi.org/10.2337/diacare.23.11.1707

M

  1. Mäkimattila, S

    1. Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.
      S Mäkimattila, A Schlenzka, M Mäntysaari, R Bergholm, P Summanen, P Saar, H Erkkilä and H Yki-Järvinen
      Diabetes Care 2000 Nov; 23 (11): 1686-1693. https://doi.org/10.2337/diacare.23.11.1686

  2. Mallows, S

    1. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.
      E S Horton, C Clinkingbeard, M Gatlin, J Foley, S Mallows and S Shen
      Diabetes Care 2000 Nov; 23 (11): 1660-1665. https://doi.org/10.2337/diacare.23.11.1660

  3. Mäntysaari, M

    1. Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.
      S Mäkimattila, A Schlenzka, M Mäntysaari, R Bergholm, P Summanen, P Saar, H Erkkilä and H Yki-Järvinen
      Diabetes Care 2000 Nov; 23 (11): 1686-1693. https://doi.org/10.2337/diacare.23.11.1686

  4. Martin, M A

    1. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study.
      R A Bell, E J Mayer-Davis, M A Martin, R B D'Agostino and S M Haffner
      Diabetes Care 2000 Nov; 23 (11): 1630-1636. https://doi.org/10.2337/diacare.23.11.1630

  5. Mathisen, A L

    1. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
      S Aronoff, S Rosenblatt, S Braithwaite, J W Egan, A L Mathisen and R L Schneider
      Diabetes Care 2000 Nov; 23 (11): 1605-1611. https://doi.org/10.2337/diacare.23.11.1605

  6. Matz, R

    1. Hypoglycemia, seizures, and pulmonary edema.
      R Matz
      Diabetes Care 2000 Nov; 23 (11): 1715. https://doi.org/10.2337/diacare.23.11.1715b

  7. Mauricio, D

    1. Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients?
      G Carreras, D Mauricio, A Pérez and A de Leiva
      Diabetes Care 2000 Nov; 23 (11): 1715-1716. https://doi.org/10.2337/diacare.23.11.1715a

  8. Mayer-Davis, E J

    1. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study.
      R A Bell, E J Mayer-Davis, M A Martin, R B D'Agostino and S M Haffner
      Diabetes Care 2000 Nov; 23 (11): 1630-1636. https://doi.org/10.2337/diacare.23.11.1630

  9. Mecca, T

    1. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
      P Raskin, L Klaff, R Bergenstal, J P Hallé, D Donley and T Mecca
      Diabetes Care 2000 Nov; 23 (11): 1666-1671. https://doi.org/10.2337/diacare.23.11.1666

  10. Mitchell, M L

    1. Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis.
      M L Mitchell, R J Hermos, C A Larson, G E Palomaki and J E Haddow
      Diabetes Care 2000 Nov; 23 (11): 1705-1706. https://doi.org/10.2337/diacare.23.11.1705

N

  1. Nagai, Y

    1. Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?
      Y Nagai, T Hayakawa, T Abe and G Nomura
      Diabetes Care 2000 Nov; 23 (11): 1703. https://doi.org/10.2337/diacare.23.11.1703b

  2. Nichols, G A

    1. Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis.
      G A Nichols, H S Glauber and J B Brown
      Diabetes Care 2000 Nov; 23 (11): 1654-1659. https://doi.org/10.2337/diacare.23.11.1654

  3. Nietzschmann, U

    1. "Lady-like": is there a latent autoimmune diabetes in the young?
      T Lohmann, U Nietzschmann and W Kiess
      Diabetes Care 2000 Nov; 23 (11): 1707-1708. https://doi.org/10.2337/diacare.23.11.1707

  4. Niskanen, L K

    1. Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance.
      R M Voutilainen-Kaunisto, M E Teräsvirta, M I Uusitupa and L K Niskanen
      Diabetes Care 2000 Nov; 23 (11): 1672-1678. https://doi.org/10.2337/diacare.23.11.1672

  5. Nomura, G

    1. Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?
      Y Nagai, T Hayakawa, T Abe and G Nomura
      Diabetes Care 2000 Nov; 23 (11): 1703. https://doi.org/10.2337/diacare.23.11.1703b

P

  1. Palomaki, G E

    1. Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis.
      M L Mitchell, R J Hermos, C A Larson, G E Palomaki and J E Haddow
      Diabetes Care 2000 Nov; 23 (11): 1705-1706. https://doi.org/10.2337/diacare.23.11.1705

  2. Park, E M

    1. Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis.
      D L Sprecher, G L Pearce, E M Park, F J Pashkow and B J Hoogwerf
      Diabetes Care 2000 Nov; 23 (11): 1648-1653. https://doi.org/10.2337/diacare.23.11.1648

  3. Pashkow, F J

    1. Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis.
      D L Sprecher, G L Pearce, E M Park, F J Pashkow and B J Hoogwerf
      Diabetes Care 2000 Nov; 23 (11): 1648-1653. https://doi.org/10.2337/diacare.23.11.1648

  4. Paz-Priel, I

    1. Are tumor necrosis factor-alpha receptor 2 levels associated with age?
      W Taha, I Paz-Priel and H Anhalt
      Diabetes Care 2000 Nov; 23 (11): 1713-1715. https://doi.org/10.2337/diacare.23.11.1713

  5. Pearce, G L

    1. Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis.
      D L Sprecher, G L Pearce, E M Park, F J Pashkow and B J Hoogwerf
      Diabetes Care 2000 Nov; 23 (11): 1648-1653. https://doi.org/10.2337/diacare.23.11.1648

  6. Pérez, A

    1. Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients?
      G Carreras, D Mauricio, A Pérez and A de Leiva
      Diabetes Care 2000 Nov; 23 (11): 1715-1716. https://doi.org/10.2337/diacare.23.11.1715a

  7. Perlman, K

    1. School attendance of children with type 1 diabetes.
      J Vetiska, L Glaab, K Perlman and D Daneman
      Diabetes Care 2000 Nov; 23 (11): 1706-1707. https://doi.org/10.2337/diacare.23.11.1706

R

  1. Raskin, P

    1. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
      P Raskin, L Klaff, R Bergenstal, J P Hallé, D Donley and T Mecca
      Diabetes Care 2000 Nov; 23 (11): 1666-1671. https://doi.org/10.2337/diacare.23.11.1666

  2. Resnick, H E

    1. Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study.
      H E Resnick, A I Vinik, A V Schwartz, S G Leveille, F L Brancati, J Balfour and J M Guralnik
      Diabetes Care 2000 Nov; 23 (11): 1642-1647. https://doi.org/10.2337/diacare.23.11.1642

  3. Rose, M

    1. Relevance of the treatment facility for disease-related knowledge of diabetic patients.
      M Rose, M Hildebrandt, H Fliege, B Seidlitz, L Cotta, T Schirop and B F Klapp
      Diabetes Care 2000 Nov; 23 (11): 1708-1709. https://doi.org/10.2337/diacare.23.11.1708

  4. Rosenblatt, S

    1. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
      S Aronoff, S Rosenblatt, S Braithwaite, J W Egan, A L Mathisen and R L Schneider
      Diabetes Care 2000 Nov; 23 (11): 1605-1611. https://doi.org/10.2337/diacare.23.11.1605

S

  1. Saar, P

    1. Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.
      S Mäkimattila, A Schlenzka, M Mäntysaari, R Bergholm, P Summanen, P Saar, H Erkkilä and H Yki-Järvinen
      Diabetes Care 2000 Nov; 23 (11): 1686-1693. https://doi.org/10.2337/diacare.23.11.1686

  2. Sampson, M

    1. Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study.
      R Taylor, R Davies, C Fox, M Sampson, J U Weaver and L Wood
      Diabetes Care 2000 Nov; 23 (11): 1612-1618. https://doi.org/10.2337/diacare.23.11.1612

  3. Schirop, T

    1. Relevance of the treatment facility for disease-related knowledge of diabetic patients.
      M Rose, M Hildebrandt, H Fliege, B Seidlitz, L Cotta, T Schirop and B F Klapp
      Diabetes Care 2000 Nov; 23 (11): 1708-1709. https://doi.org/10.2337/diacare.23.11.1708

  4. Schlenzka, A

    1. Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.
      S Mäkimattila, A Schlenzka, M Mäntysaari, R Bergholm, P Summanen, P Saar, H Erkkilä and H Yki-Järvinen
      Diabetes Care 2000 Nov; 23 (11): 1686-1693. https://doi.org/10.2337/diacare.23.11.1686

  5. Schneider, R L

    1. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
      S Aronoff, S Rosenblatt, S Braithwaite, J W Egan, A L Mathisen and R L Schneider
      Diabetes Care 2000 Nov; 23 (11): 1605-1611. https://doi.org/10.2337/diacare.23.11.1605

  6. Schwartz, A V

    1. Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study.
      H E Resnick, A I Vinik, A V Schwartz, S G Leveille, F L Brancati, J Balfour and J M Guralnik
      Diabetes Care 2000 Nov; 23 (11): 1642-1647. https://doi.org/10.2337/diacare.23.11.1642

  7. Seidlitz, B

    1. Relevance of the treatment facility for disease-related knowledge of diabetic patients.
      M Rose, M Hildebrandt, H Fliege, B Seidlitz, L Cotta, T Schirop and B F Klapp
      Diabetes Care 2000 Nov; 23 (11): 1708-1709. https://doi.org/10.2337/diacare.23.11.1708

  8. Shen, S

    1. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.
      E S Horton, C Clinkingbeard, M Gatlin, J Foley, S Mallows and S Shen
      Diabetes Care 2000 Nov; 23 (11): 1660-1665. https://doi.org/10.2337/diacare.23.11.1660

  9. Sheu, W H

    1. Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia.
      T S Tai, W H Sheu, W J Lee, H T Yao and M T Chiang
      Diabetes Care 2000 Nov; 23 (11): 1703-1704. https://doi.org/10.2337/diacare.23.11.1703a

  10. Snyder, J W

    1. Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes.
      H P Wetzler and J W Snyder
      Diabetes Care 2000 Nov; 23 (11): 1637-1641. https://doi.org/10.2337/diacare.23.11.1637

  11. Sprecher, D L

    1. Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis.
      D L Sprecher, G L Pearce, E M Park, F J Pashkow and B J Hoogwerf
      Diabetes Care 2000 Nov; 23 (11): 1648-1653. https://doi.org/10.2337/diacare.23.11.1648

  12. Stöckl, D

    1. Evaluating clinical accuracy of systems for self-monitoring of blood glucose by error grid analysis: comment on constructing the "upper A-line".
      D Stöckl, K Dewitte, C Fierens and L M Thienpont
      Diabetes Care 2000 Nov; 23 (11): 1711-1712. https://doi.org/10.2337/diacare.23.11.1711

  13. Summanen, P

    1. Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.
      S Mäkimattila, A Schlenzka, M Mäntysaari, R Bergholm, P Summanen, P Saar, H Erkkilä and H Yki-Järvinen
      Diabetes Care 2000 Nov; 23 (11): 1686-1693. https://doi.org/10.2337/diacare.23.11.1686

T

  1. Taha, W

    1. Are tumor necrosis factor-alpha receptor 2 levels associated with age?
      W Taha, I Paz-Priel and H Anhalt
      Diabetes Care 2000 Nov; 23 (11): 1713-1715. https://doi.org/10.2337/diacare.23.11.1713

  2. Tai, T S

    1. Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia.
      T S Tai, W H Sheu, W J Lee, H T Yao and M T Chiang
      Diabetes Care 2000 Nov; 23 (11): 1703-1704. https://doi.org/10.2337/diacare.23.11.1703a

  3. Tang, M

    1. Prevalence of diabetes in Canadian adults aged 40 years or older.
      M Tang and Y Chen
      Diabetes Care 2000 Nov; 23 (11): 1704-1705. https://doi.org/10.2337/diacare.23.11.1704

  4. Taylor, R

    1. Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study.
      R Taylor, R Davies, C Fox, M Sampson, J U Weaver and L Wood
      Diabetes Care 2000 Nov; 23 (11): 1612-1618. https://doi.org/10.2337/diacare.23.11.1612

  5. Teräsvirta, M E

    1. Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance.
      R M Voutilainen-Kaunisto, M E Teräsvirta, M I Uusitupa and L K Niskanen
      Diabetes Care 2000 Nov; 23 (11): 1672-1678. https://doi.org/10.2337/diacare.23.11.1672

  6. Thienpont, L M

    1. Evaluating clinical accuracy of systems for self-monitoring of blood glucose by error grid analysis: comment on constructing the "upper A-line".
      D Stöckl, K Dewitte, C Fierens and L M Thienpont
      Diabetes Care 2000 Nov; 23 (11): 1711-1712. https://doi.org/10.2337/diacare.23.11.1711

  7. Tofler, G H

    1. von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes.
      D Feng, S E Bursell, A C Clermont, I Lipinska, L P Aiello, L Laffel, G L King and G H Tofler
      Diabetes Care 2000 Nov; 23 (11): 1694-1698. https://doi.org/10.2337/diacare.23.11.1694

U

  1. Uusitupa, M I

    1. Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance.
      R M Voutilainen-Kaunisto, M E Teräsvirta, M I Uusitupa and L K Niskanen
      Diabetes Care 2000 Nov; 23 (11): 1672-1678. https://doi.org/10.2337/diacare.23.11.1672

V

  1. Vetiska, J

    1. School attendance of children with type 1 diabetes.
      J Vetiska, L Glaab, K Perlman and D Daneman
      Diabetes Care 2000 Nov; 23 (11): 1706-1707. https://doi.org/10.2337/diacare.23.11.1706

  2. Vinik, A I

    1. Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study.
      H E Resnick, A I Vinik, A V Schwartz, S G Leveille, F L Brancati, J Balfour and J M Guralnik
      Diabetes Care 2000 Nov; 23 (11): 1642-1647. https://doi.org/10.2337/diacare.23.11.1642

  3. Voutilainen-Kaunisto, R M

    1. Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance.
      R M Voutilainen-Kaunisto, M E Teräsvirta, M I Uusitupa and L K Niskanen
      Diabetes Care 2000 Nov; 23 (11): 1672-1678. https://doi.org/10.2337/diacare.23.11.1672

W

  1. Weaver, J U

    1. Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study.
      R Taylor, R Davies, C Fox, M Sampson, J U Weaver and L Wood
      Diabetes Care 2000 Nov; 23 (11): 1612-1618. https://doi.org/10.2337/diacare.23.11.1612

  2. Wetzler, H P

    1. Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes.
      H P Wetzler and J W Snyder
      Diabetes Care 2000 Nov; 23 (11): 1637-1641. https://doi.org/10.2337/diacare.23.11.1637

  3. Wood, L

    1. Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study.
      R Taylor, R Davies, C Fox, M Sampson, J U Weaver and L Wood
      Diabetes Care 2000 Nov; 23 (11): 1612-1618. https://doi.org/10.2337/diacare.23.11.1612

Y

  1. Yao, H T

    1. Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia.
      T S Tai, W H Sheu, W J Lee, H T Yao and M T Chiang
      Diabetes Care 2000 Nov; 23 (11): 1703-1704. https://doi.org/10.2337/diacare.23.11.1703a

  2. Yki-Järvinen, H

    1. Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.
      S Mäkimattila, A Schlenzka, M Mäntysaari, R Bergholm, P Summanen, P Saar, H Erkkilä and H Yki-Järvinen
      Diabetes Care 2000 Nov; 23 (11): 1686-1693. https://doi.org/10.2337/diacare.23.11.1686

Z

  1. Zack, M M

    1. Moderate-intensity physical activity and fasting insulin levels in women.
      C J Caspersen, M M Zack and J E Fulton
      Diabetes Care 2000 Nov; 23 (11): 1712-1713. https://doi.org/10.2337/diacare.23.11.1712
Back to top